[DOI] [PubMed] [Google Scholar] 18.Dassanayake R.S., Acharya S., Abidi N
Compared to placebo, the treatment with intramuscular acetyl-l-carnitine significantly reduced weekly mean pain on the VAS, whilst during the open-label part of the study, oral acetyl-l-carnitine improved symptoms in the entire cohort, with no safety issues [81] (Table 2)
Safe for sensitive skin, dermatologically tested, and free from harsh ingredients
Suggested dosage: As per the guidance of your healthcare practitioner
Expert Opinions Health professionals worldwide agree that GLP-1 treatments are a game-changer for weight loss
Such trials hopefully will also identify whether lower doses might thus reduce even further any risks from initial and/or long-term use of such drugs. Not the RECOVER or Scripps trials, though